--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) (Spectrum) and Allos Therapeutics, Inc. …
LAHORE - Bear-run continued at the Pakistan Stock Exchange on Wednesday as investors continued ... On Wednesday, Atlas Honda ALTH (ATLH) announced 3QFY18 financial results reporting earnings of Rs1.2 billion (EPS 11.3), up 17 …
Old Versus New Paradigm in Biotechnology Collaborations In addition ... Allos Therapeutics, Inc. (ALTH) developed Folotyn® [pralatrexate injection], a folate analogue metabolic inhibitor, and began commercializing the product in the …
(Reuters) - Shares of Allos Therapeutics Inc ALTH.O recouped much of their Monday losses after ... dropped its pursuit of the company last year. Allos’s stock had been trading around $1.79 until last Friday. “Someone clearly sold a big …
The top pre-market NASDAQ stock market gainers are ... Shares of Allos Therapeutics, Inc. (ALTH) gained 5.91 percent to $4.12 in the pre-market session. The company said the Journal of Clinical Oncology has published data from its pivotal …
Each of these rates an “A” (“strong buy”) or “B” overall (“buy”). Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures.
Trump has taken credit for the soaring stock market with a new slogan ... state House seat in district Trump won by 49 points GOP's tax reform bait-and-switch will widen inequality Pentagon budget euphoria could be short-lived MORE …
[ID:nSGE64H0HC] RESOURCE CAPITAL CORP (RSO.N), $5.73, down 15 pct The company said it intends to offer about $80 million of its common stock in a public offering ... [ID:nSGE64H0FO] ALLOS THERAPEUTICS INC ALTH.O, $7.80, …
Jan 8 (Reuters) - J.P. Morgan Securities started coverage of Allos Therapeutics Inc ALTH.O with an “overweight” rating ... The near-term driver for the stock would be data from the mid-stage study of the drug in lung cancer against OSI …